Literature DB >> 21001620

Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.

H EAGLE, H J MAGNUSON, R FLEISCHMAN.   

Abstract

Entities:  

Keywords:  ARSENIC/toxicity; MERCAPTOPROPANOL/therapy

Mesh：

Substances：

Year:  1946        PMID： 21001620      PMCID： PMC435584          DOI： 10.1172/jci101728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  Chemical constitution and toxicity.

Authors:  E Walker
Journal:  Biochem J       Date:  1928       Impact factor: 3.857

2.  BAL (BRITISH ANTI-LEWISITE).

Authors:  L L Waters; C Stock
Journal:  Science       Date:  1945-12-14       Impact factor: 47.728

3.  ENZYME SYSTEMS CONTAINING ACTIVE SULFHYDRYL GROUPS. THE ROLE OF GLUTATHIONE.

Authors:  E S Barron; T P Singer
Journal:  Science       Date:  1943-04-16       Impact factor: 47.728

4.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION.

Authors:  J A Luetscher; H Eagle; W T Longcope; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  4 in total
  2 in total

Review 1.  The role of chelation in the treatment of arsenic and mercury poisoning.

Authors:  Michael J Kosnett
Journal:  J Med Toxicol       Date:  2013-12

2.  Defining cutaneous molecular pathobiology of arsenicals using phenylarsine oxide as a prototype.

Authors:  Ritesh K Srivastava; Changzhao Li; Zhiping Weng; Anupam Agarwal; Craig A Elmets; Farrukh Afaq; Mohammad Athar
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.